MAD1L1 anticorps (AA 124-151) (APC)

N° du produit ABIN1911155

Détail du produit anti-MAD1L1 anticorps (APC)

Antigène: MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))

Épitope: AA 124-151

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAD1L1 est conjugé à/à la APC

Application: Western Blotting (WB), ELISA

Specificité: This MAD1L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 124-151 amino acids from the N-terminal region of human MAD1L1.

Purification: Protein A purified

Isotype: IgG

Information d'application

Indications d'application: Approved: ELISA, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, no preservatives added

Agent conservateur: Without preservative

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Date de péremption: 6 months

Détails sur MAD1L1

Antigène: MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))

Autre désignation: MAD1L1 / MAD1 (MAD1L1 Produits)

Synonymes: anticorps MAD1, anticorps PIG9, anticorps TP53I9, anticorps TXBP181, anticorps AI173502, anticorps AW550425, anticorps Mad1, anticorps zgc:56571, anticorps MAD1-like protein 1, anticorps mitotic arrest deficient 1 like 1, anticorps MAD1 mitotic arrest deficient like 1, anticorps MAD1 mitotic arrest deficient 1-like 1, anticorps deafness, autosomal recessive 19, anticorps MAD1L1, anticorps Mad1l1, anticorps mad1l1, anticorps DFNB19

Sujet: Name/Gene ID: MAD1L1

Synonyms: MAD1L1, HMAD1, MAD1, MAD1-like protein 1, Tax-binding protein 181, TP53I9, PIG9, HSMAD1, Tax1-binding protein txbp181, TXBP181

ID gène: 8379

Pathways: M Phase